240 related articles for article (PubMed ID: 21375075)
1. Vascular disease in systemic sclerosis.
Poredos P
Vasa; 2011 Jan; 40(1):3-4. PubMed ID: 21375075
[No Abstract] [Full Text] [Related]
2. Systemic sclerosis - a systematic overview: part 1 - disease characteristics and classification, pathophysiologic concepts, and recommendations for diagnosis and surveillance.
Klein-Weigel P; Opitz C; Riemekasten G
Vasa; 2011 Jan; 40(1):6-19. PubMed ID: 21283969
[TBL] [Abstract][Full Text] [Related]
3. Advances in the diagnosis and management of scleroderma-related vascular complications.
Kerin K; Yost JH
Compr Ther; 1998; 24(11-12):574-81. PubMed ID: 9847974
[TBL] [Abstract][Full Text] [Related]
4. Management of systemic sclerosis.
Lim IG; Schrieber L
Isr Med Assoc J; 2002 Nov; 4(11 Suppl):953-7. PubMed ID: 12455189
[No Abstract] [Full Text] [Related]
5. [Management of patients with systemic sclerosis].
Wiesik-Szewczyk E; Olesińska M
Pol Merkur Lekarski; 2010 May; 28(167):421-3. PubMed ID: 20568411
[TBL] [Abstract][Full Text] [Related]
6. Management of Raynaud Phenomenon and Digital Ulcers in Scleroderma.
Cappelli L; Wigley FM
Rheum Dis Clin North Am; 2015 Aug; 41(3):419-38. PubMed ID: 26210127
[TBL] [Abstract][Full Text] [Related]
7. [Systemic scleroderma].
Hunzelmann N
Hautarzt; 2013 Apr; 64(4):299-310; quiz 311-2. PubMed ID: 23576170
[TBL] [Abstract][Full Text] [Related]
8. Systemic sclerosis - a systematic overview: part 2 - immunosuppression, treatment of SSc-associated vasculopathy, and treatment of pulmonary arterial hypertension.
Opitz C; Klein-Weigel PF; Riemekasten G
Vasa; 2011 Jan; 40(1):20-30. PubMed ID: 21283970
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and management of vascular disease in systemic sclerosis.
Yost JH; Spencer-Green G
Compr Ther; 1993; 19(2):53-9. PubMed ID: 8370246
[TBL] [Abstract][Full Text] [Related]
10. Update of EULAR recommendations for the treatment of systemic sclerosis.
Kowal-Bielecka O; Fransen J; Avouac J; Becker M; Kulak A; Allanore Y; Distler O; Clements P; Cutolo M; Czirjak L; Damjanov N; Del Galdo F; Denton CP; Distler JHW; Foeldvari I; Figelstone K; Frerix M; Furst DE; Guiducci S; Hunzelmann N; Khanna D; Matucci-Cerinic M; Herrick AL; van den Hoogen F; van Laar JM; Riemekasten G; Silver R; Smith V; Sulli A; Tarner I; Tyndall A; Welling J; Wigley F; Valentini G; Walker UA; Zulian F; Müller-Ladner U;
Ann Rheum Dis; 2017 Aug; 76(8):1327-1339. PubMed ID: 27941129
[TBL] [Abstract][Full Text] [Related]
11. [Pathogenic mechanisms in systemic sclerosis and their therapeutical consequences. Part 2: treatment].
Zuber JP; Chizzolini C; Leimgruber A; Bart PA; Spertini F
Rev Med Suisse; 2006 Apr; 2(62):1058, 1060-6. PubMed ID: 16711151
[TBL] [Abstract][Full Text] [Related]
12. What is your diagnosis? Progressive systemic sclerosis (scleroderma).
Elston DM
Cutis; 2005 Dec; 76(6):357, 385-7. PubMed ID: 16438423
[No Abstract] [Full Text] [Related]
13. Classification and pathogenesis of scleroderma.
Winkelmann RK
Mayo Clin Proc; 1971 Feb; 46(2):83-91. PubMed ID: 4925984
[No Abstract] [Full Text] [Related]
14. [Therapy of systemic sclerosis].
Meurer M; Rehberger P
Hautarzt; 2007 Oct; 58(10):851-7. PubMed ID: 17849090
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary artery hypertension as the presenting feature of systemic sclerosis sine scleroderma.
Pauling JD; Gunawardena H; Coghlan JG; Easaw J; Suntharalingam J; McHugh NJ
Rheumatology (Oxford); 2008 Sep; 47(9):1431-2. PubMed ID: 18603658
[No Abstract] [Full Text] [Related]
16. Systemic sclerosis: an update.
Varga J
Bull NYU Hosp Jt Dis; 2008; 66(3):198-202. PubMed ID: 18937632
[TBL] [Abstract][Full Text] [Related]
17. [Pulmonary arterial hypertension in collagen disease: experiences of the German Network for Systemic Scleroderma].
Hunzelmann N; Riemekasten G
Dtsch Med Wochenschr; 2006 Dec; 131(49 Suppl 9):S325-7. PubMed ID: 17139598
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary arterial hypertension in systemic sclerosis: can we predict responders for successful therapy?
Sasahara AA
J Rheumatol; 2009 Apr; 36(4):665-6. PubMed ID: 19342719
[No Abstract] [Full Text] [Related]
19. Raynaud's phenomenon, scleroderma, overlap syndromes, and other fibrosing syndromes.
Curr Opin Rheumatol; 1997 Nov; 9(6):B199-206. PubMed ID: 9375289
[No Abstract] [Full Text] [Related]
20. Treatment of Raynaud phenomenon in systemic sclerosis.
Sinnathurai P; Schrieber L
Intern Med J; 2013 May; 43(5):476-83. PubMed ID: 23347192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
